Skip to Main Content

Author Details

Elaine F Reed
University of California Los Angeles
1980
295
60
PMIDPaper TitleJournal TitlePublished Year
37838218Report of the 2022 Banff Heart Concurrent: Focus on non-human leukocyte antigen antibodies in rejection and the pathology of "mixed" rejection.Am J Transplant2024
37838218Report of the 2022 Banff Heart Concurrent: Focus on non-human leukocyte antigen antibodies in rejection and the pathology of "mixed" rejection.Am J Transplant2024
37527494Non-HLA Antibodies to G Protein-coupled Receptors in Pediatric Kidney Transplant Recipients: Short- and Long-term Clinical Outcomes.Transplantation2024
37527494Non-HLA Antibodies to G Protein-coupled Receptors in Pediatric Kidney Transplant Recipients: Short- and Long-term Clinical Outcomes.Transplantation2024
35974436Apheresis of Deceased Donors as a New Source of Mobilized Peripheral Blood Hematopoietic Stem Cells for Transplant Tolerance.Transplantation2023
35974436Apheresis of Deceased Donors as a New Source of Mobilized Peripheral Blood Hematopoietic Stem Cells for Transplant Tolerance.Transplantation2023
37749817Virtual Crossmatch: By Any Other Name.Transplantation2023
37567451Disulfide-HMGB1 signals through TLR4 and TLR9 to induce inflammatory macrophages capable of innate-adaptive crosstalk in human liver transplantation.Am J Transplant2023
37876917Immune Features of Disparate Liver Transplant Outcomes in Female Hispanics With Nonalcoholic Steatohepatitis.Transplant Direct2023
37153624Longitudinal analysis of SARS-CoV-2 infection and vaccination in the LA-SPARTA cohort reveals increased risk of infection in vaccinated Hispanic participants.Front Immunol2023
37398658Vascular and Non-HLA autoantibody profiles in hospitalized patients with COVID-19.Front Immunol2023
37205661Plasma proteome perturbation for CMV DNAemia in kidney transplantation.PLoS One2023
36881871Lipophilic Statins Inhibit YAP Nuclear Localization, Coactivator Activity, and Migration in Response to Ligation of HLA Class I Molecules in Endothelial Cells: Role of YAP Multisite Phosphorylation.J Immunol2023
36944607Virtual and Reality: An Analysis of the UCLA Virtual Crossmatch Exchanges.Transplantation2023
36695615Sensitization in transplantation: Assessment of Risk 2022 Working Group Meeting Report.Am J Transplant2023
36932020Corrigendum to 'Sensitization in transplantation: Assessment of Risk 2022 Working Group Meeting Report' [American Journal of Transplantation 23 (2023) 133-149].Am J Transplant2023
37749817Virtual Crossmatch: By Any Other Name.Transplantation2023
37876917Immune Features of Disparate Liver Transplant Outcomes in Female Hispanics With Nonalcoholic Steatohepatitis.Transplant Direct2023
37567451Disulfide-HMGB1 signals through TLR4 and TLR9 to induce inflammatory macrophages capable of innate-adaptive crosstalk in human liver transplantation.Am J Transplant2023
37153624Longitudinal analysis of SARS-CoV-2 infection and vaccination in the LA-SPARTA cohort reveals increased risk of infection in vaccinated Hispanic participants.Front Immunol2023
36944607Virtual and Reality: An Analysis of the UCLA Virtual Crossmatch Exchanges.Transplantation2023
37205661Plasma proteome perturbation for CMV DNAemia in kidney transplantation.PLoS One2023
37398658Vascular and Non-HLA autoantibody profiles in hospitalized patients with COVID-19.Front Immunol2023
36881871Lipophilic Statins Inhibit YAP Nuclear Localization, Coactivator Activity, and Migration in Response to Ligation of HLA Class I Molecules in Endothelial Cells: Role of YAP Multisite Phosphorylation.J Immunol2023
36695615Sensitization in transplantation: Assessment of Risk 2022 Working Group Meeting Report.Am J Transplant2023
36932020Corrigendum to 'Sensitization in transplantation: Assessment of Risk 2022 Working Group Meeting Report' [American Journal of Transplantation 23 (2023) 133-149].Am J Transplant2023
34464505The allograft injury marker CXCL9 determines prognosis of anti-HLA antibodies after lung transplantation.Am J Transplant2022
35657013Long term tolerability and clinical outcomes associated with tocilizumab in the treatment of refractory antibody mediated rejection (AMR) in pediatric renal transplant recipients.Clin Transplant2022
35395132Operational tolerance is not always permanent: A 10-year prospective study in pediatric liver transplantation recipients.Liver Transpl2022
35586986PARIS and SPARTA: Finding the Achilles' Heel of SARS-CoV-2.mSphere2022
36165200Cross-Talk between HLA Class I and TLR4 Mediates P-Selectin Surface Expression and Monocyte Capture to Human Endothelial Cells.J Immunol2022
35444663The Women of FOCIS: Promoting Equality and Inclusiveness in a Professional Federation of Clinical Immunology Societies.Front Immunol2022
35999654Opposite Effects of Src Family Kinases on YAP and ERK Activation in Pancreatic Cancer Cells: Implications for Targeted Therapy.Mol Cancer Ther2022
35938682Malnutrition and immune cell subsets in children undergoing kidney transplantation.Pediatr Transplant2022
35490714Molecular Signature of Antibody-Mediated Chronic Vasculopathy in Heart Allografts in a Novel Mouse Model.Am J Pathol2022
36330055Phosphorylation of S6RP in peritubular capillaries of kidney grafts and circulating HLA donor-specific antibodies.Front Med (Lausanne)2022
36263043A multi-faceted approach to sex and gender equity in solid organ transplantation: The Women in Transplantation Initiative of The Transplantation Society.Front Immunol2022
36192241Corrigendum to "T cell senescence and impaired CMV-specific response are associated with infection risk in kidney transplant recipients" [Hum. Immunol. 83(4) (2022) 273-280].Hum Immunol2022
36644348Preservation of Antiviral Immunologic Efficacy Without Alloimmunity After Switch to Belatacept in Calcineurin Inhibitor-Intolerant Patients.Kidney Int Rep2022
34464505The allograft injury marker CXCL9 determines prognosis of anti-HLA antibodies after lung transplantation.Am J Transplant2022
35251005Variability in Donor-Derived Cell-Free DNA Scores to Predict Mortality in Heart Transplant Recipients - A Proof-of-Concept Study.Front Immunol2022
35190203T cell senescence and impaired CMV-specific response are associated with infection risk in kidney transplant recipients.Hum Immunol2022
35181606Mass cytometry reveals single-cell kinetics of cytotoxic lymphocyte evolution in CMV-infected renal transplant patients.Proc Natl Acad Sci U S A2022
35586986PARIS and SPARTA: Finding the Achilles' Heel of SARS-CoV-2.mSphere2022
35444663The Women of FOCIS: Promoting Equality and Inclusiveness in a Professional Federation of Clinical Immunology Societies.Front Immunol2022
35395132Operational tolerance is not always permanent: A 10-year prospective study in pediatric liver transplantation recipients.Liver Transpl2022
35490714Molecular Signature of Antibody-Mediated Chronic Vasculopathy in Heart Allografts in a Novel Mouse Model.Am J Pathol2022
35657013Long term tolerability and clinical outcomes associated with tocilizumab in the treatment of refractory antibody mediated rejection (AMR) in pediatric renal transplant recipients.Clin Transplant2022
36644348Preservation of Antiviral Immunologic Efficacy Without Alloimmunity After Switch to Belatacept in Calcineurin Inhibitor-Intolerant Patients.Kidney Int Rep2022
35999654Opposite Effects of Src Family Kinases on YAP and ERK Activation in Pancreatic Cancer Cells: Implications for Targeted Therapy.Mol Cancer Ther2022
  • 1 - 50 of 590

Recommended Authors

Centre Hospitalier Universitaire de Nantes, Nantes Universite, Inserm
Career Start Year 2001
Number of shared co-authors 0
University of Toronto
Career Start Year 1996
Number of shared co-authors 0
University of Virginia School of Medicine.
Career Start Year 1995
Number of shared co-authors 1
University of Virginia
Career Start Year 1995
Number of shared co-authors 0
Ulm University
Career Start Year 1995
Number of shared co-authors 0
University Health Network
Career Start Year 1992
Number of shared co-authors 1
Universite de Montreal
Career Start Year 1991
Number of shared co-authors 1
INSERM UMRS, University Paris Cite
Career Start Year 1990
Number of shared co-authors 0
University of Oklahoma Health Sciences Center
Career Start Year 1990
Number of shared co-authors 6
Heidelberg University
Career Start Year 1990
Number of shared co-authors 0
Boston Children's Hospital
Career Start Year 1987
Number of shared co-authors 1
Universite de Montreal
Career Start Year 1985
Number of shared co-authors 2
University of Cambridge Clinical School, LIFNanoRx Ltd
Career Start Year 1984
Number of shared co-authors 0
University of Rochester Medical Center
Career Start Year 1983
Number of shared co-authors 1
University of Pittsburgh
Career Start Year 1982
Number of shared co-authors 2
Center for Translational Immunology, Benaroya Research Institute at Virginia Mason
Career Start Year 1982
Number of shared co-authors 5
Columbia University Irving Medical Center, New York-Presbyterian Hospital
Career Start Year 1982
Number of shared co-authors 0
Center for Cellular Engineering, NIH Clinical Center, National Institutes of Health
Career Start Year 1981
Number of shared co-authors 0
University of Texas Southwestern Medical Center
Career Start Year 1981
Number of shared co-authors 7
Translational and Clinical Research Institute, Newcastle University
Career Start Year 1981
Number of shared co-authors 1
University of Nebraska Medical Center
Career Start Year 1980
Number of shared co-authors 0
Yale University School of Medicine
Career Start Year 1980
Number of shared co-authors 0
8Benaroya Research Institute
Career Start Year 1978
Number of shared co-authors 3
Oregon Health & Science University
Career Start Year 1977
Number of shared co-authors 1
Universite de Strasbourg
Career Start Year 1976
Number of shared co-authors 1
Emory University
Career Start Year 1974
Number of shared co-authors 2
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1971
Number of shared co-authors 1
Allergy and Clinical Immunology, University of California at Davis
Career Start Year 1967
Number of shared co-authors 0
University of British Columbia
Career Start Year 1965
Number of shared co-authors 3
Monash University
Career Start Year 1958
Number of shared co-authors 1

Collaborators

University of California Los Angeles
Co-authored papers 31
University of California Los Angeles
Co-authored papers 27
University of California los angeles
Co-authored papers 21
Co-authored papers 16
Ronald Reagan university of california los angeles Medical Center
Co-authored papers 15
UC Davis Medical Center
Co-authored papers 12
Co-authored papers 10
Clinical Trials Center, Cardiovascular Research Foundation
Co-authored papers 10
University of California los angeles
Co-authored papers 9
University of California Los Angeles, David Geffen School of Medicine
Co-authored papers 8
university of california los angeles Medical Center
Co-authored papers 8
David Geffen School of Medicine at University of California los angeles
Co-authored papers 8
The University of Texas Health Science Center at Houston School of Dentistry
Co-authored papers 7
University of Nebraska Medical Center
Co-authored papers 7
Co-authored papers 7
David Geffen School of Medicine
Co-authored papers 6
Washington University in St. Louis School of Medicine
Co-authored papers 6
College of Medicine, University of Florida
Co-authored papers 6
Co-authored papers 6
Co-authored papers 5
university of california los angeles Stein Eye Institute (E.T.
Co-authored papers 5
Co-authored papers 5
David Geffen School of Medicine, university of california los angeles Medical Center
Co-authored papers 5
Co-authored papers 4
Co-authored papers 4
David Geffen School of Medicine, University of California los angeles
Co-authored papers 4
University of Alberta
Co-authored papers 4
Columbia University Irving Medical Center
Co-authored papers 3
Ronald Reagan university of california los angeles Medical Center Los Angeles CA.
Co-authored papers 3
BioCryst Pharmaceuticals
Co-authored papers 3